Lupus

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Egerer, K
Right arrow Articles by Dörner, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Egerer, K
Right arrow Articles by Dörner, T
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Lupus, Vol. 9, No. 8, 614-621 (2000)
DOI: 10.1191/096120300678828749

Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus

K Egerer

Department of Rheumatology and Clinical Immunology, Charité University Hospital, Humboldt University of Berlin, Berlin, Germany;

E Feist

Department of Rheumatology and Clinical Immunology, Charité University Hospital, Humboldt University of Berlin, Berlin, Germany; Department of Rheumatology and Clinical Immunology, Charité University Hospital, Schumannstraûe 20=21, D-10117 Berlin, Germany

U Rohr

Department of Anesthesiology and Critical Care Medicine, Charité University Hospital, Humboldt University of Berlin, Berlin, Germany

A Pruss

Institute of Transfusion Medicine, Charité and University Hospital, Humboldt University of Berlin, Berlin, Germany

G-R Burmester

T Dörner

Department of Rheumatology and Clinical Immunology, Charité University Hospital, Humboldt University of Berlin, Berlin, Germany;

To improve monitoring of immunological and disease activity, we determined soluble markers of activity of the monocyte/macrophage system (sCD14) and the vascular endothelium (sE-selectin, sICAM-1) in patients with systemic lupus erythematosus (SLE) and primary Sjögren' syndrome (pSS) in comparison to patients with infections or sepsis.

Concentrations of sCD14, sICAM-1 and sE-selectin (soluble CD14, ICAM-1 and E-selectin, respectively) were measured in serum samples from patients with SLE and pSS, patients with sepsis, different infectious diseases and healthy controls using ELISA systems.

Elevated levels of sE-selectin and sICAM-1 were detected in patients with SLE as well as sepsis, in contrast to patients with a localized infection (SLE and sepsis, respectively, versus infection P < 0.001; Kruskal–Wallis test). Levels of sCD14 were persistently elevated in sera from patients with SLE, whereas these values decreased rapidly after effective therapy in patients with sepsis or infection. A continuous elevation of all of these three parameters was associated with a fatal outcome in patients with sepsis as well as in patients with SLE.

Combined elevation of sCD14, sICAM-1 and sE-selectin correlates with the prognosis in patients with active SLE and indicates a remarkable immune activation involving the monocyte/macrophage system and the endothelium comparable to an activation found only in patients with sepsis.

Key Words: SLE • sepsis • endotoxin • sCD 14 • adhesion molecules


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
LupusHome page
G. Yao, Z. Liu, X Zhang, C. Zheng, H. Chen, C. Zeng, and L. Li
Circulating thrombomodulin and vascular cell adhesion molecule-1 and renal vascular lesion in patients with lupus nephritis
Lupus, August 1, 2008; 17(8): 720 - 726.
[Abstract] [PDF]


Home page
LupusHome page
G Ferraccioli and G Romano
Renal interstitial cells, proteinuria and progression of lupus nephritis: new frontiers for old factors
Lupus, June 1, 2008; 17(6): 533 - 540.
[Abstract] [PDF]


Home page
J. Immunol.Home page
X. He, T. R. Schoeb, A. Panoskaltsis-Mortari, K. R. Zinn, R. A. Kesterson, J. Zhang, S. Samuel, M. J. Hicks, M. J. Hickey, and D. C. Bullard
Deficiency of P-Selectin or P-Selectin Glycoprotein Ligand-1 Leads to Accelerated Development of Glomerulonephritis and Increased Expression of CC Chemokine Ligand 2 in Lupus-Prone Mice
J. Immunol., December 15, 2006; 177(12): 8748 - 8756.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. Fukuda, N. Kumagai, K. Yamamoto, Y. Fujitsu, N. Chikamoto, and T. Nishida
Potentiation of Lipopolysaccharide-Induced Chemokine and Adhesion Molecule Expression in Corneal Fibroblasts by Soluble CD14 or LPS-Binding Protein
Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3095 - 3101.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
M J Lewis and D D'Cruz
Adhesion molecules, mycophenolate mofetil and systemic lupus erythematosus
Lupus, March 1, 2005; 14(3_suppl): s17 - s26.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
A. L. Hepburn, J. C. Mason, and K. A. Davies
Expression of Fc{gamma} and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis
Rheumatology, May 1, 2004; 43(5): 547 - 554.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Bas, B. R. Gauthier, U. Spenato, S. Stingelin, and C. Gabay
CD14 Is an Acute-Phase Protein
J. Immunol., April 1, 2004; 172(7): 4470 - 4479.
[Abstract] [Full Text] [PDF]